Literature DB >> 19674619

Hyperimmune egg powder for the treatment of irritable bowel syndrome: A case series.

Mark W Morningstar1.   

Abstract

OBJECTIVE: To demonstrate the benefits of a hyperimmune egg powder supplement for treating irritable bowel syndrome in 2 patients. CLINICAL FEATURES: The first patient, not under chiropractic care, had been diagnosed with irritable bowel syndrome by her primary care physician. She sought care due to failure of several other alternative therapies. Her primary care physician ordered specific dietary modifications, yet this regimen did not appear to improve her symptoms. The second patient, also diagnosed with irritable bowel syndrome by her primary care physician, decided to seek care because the attending physician was concurrently treating her for idiopathic scoliosis, and both treatments could be administered at 1 office visit. Her primary reason for seeking this treatment was her longstanding episodic intestinal cramping and diarrhea. She overheard another patient in the same clinic discussing how the hyperimmune egg powder had alleviated her digestive complaints and decided to undergo a 2-week trial of the hyperimmune egg powder. INTERVENTION AND OUTCOME: The first subject was given a 31- day supply of the hyperimmune egg powder. She reported significant subjective improvement in frequency of defecation and stool consistency after 48 hours. She kept a daily journal to monitor her bowel habits during the trial period. The second subject was provided a 15-day supply of hyperimmune egg powder and instructed to keep the same daily journal to monitor her bowel habits. During the second week of the trial, she noticed less frequent bowel habits and a more solid stool consistency. However, shortly after she stopped taking the hyperimmune egg powder, the pre-trial symptoms returned. Because of this, she was put back on the hyperimmune egg powder, and the symptoms improved thereafter.
CONCLUSION: The addition of hyperimmune egg powder into an ordinary daily diet may have improved bowel function in 2 subjects, at least subjectively. However, it is unclear whether the subjective improvements are due to the hyperimmune egg powder or any psychosomatic effect created by physician contact, regardless of treatment type. This study should be repeated on a larger scale with a control group before any conclusions are made.

Entities:  

Year:  2004        PMID: 19674619      PMCID: PMC2646983          DOI: 10.1016/S0899-3467(07)60061-5

Source DB:  PubMed          Journal:  J Chiropr Med        ISSN: 1556-3707


  15 in total

Review 1.  Gut flora in health and disease.

Authors:  Francisco Guarner; Juan-R Malagelada
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

Review 2.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

Review 3.  Chemokines--chemotactic cytokines that mediate inflammation.

Authors:  A D Luster
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

4.  Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.

Authors:  M Pimentel; E J Chow; H C Lin
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

Review 5.  Hormones, lymphohemopoietic cytokines and the neuroimmune axis.

Authors:  R W Johnson; S Arkins; R Dantzer; K W Kelley
Journal:  Comp Biochem Physiol A Physiol       Date:  1997-03

Review 6.  Inhibition of growth by pro-inflammatory cytokines: an integrated view.

Authors:  R W Johnson
Journal:  J Anim Sci       Date:  1997-05       Impact factor: 3.159

7.  One-year follow-up of newly diagnosed irritable bowel syndrome patients.

Authors:  A Ruigómez; M A Wallander; S Johansson; L A García Rodríguez
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

Review 8.  Irritable bowel syndrome: disease definition and symptom description.

Authors:  N J Talley
Journal:  Eur J Surg Suppl       Date:  1998

9.  The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

Authors:  A P S Hungin; P J Whorwell; J Tack; F Mearin
Journal:  Aliment Pharmacol Ther       Date:  2003-03-01       Impact factor: 8.171

10.  Pilot study on the effect of hyperimmune egg protein on elevated cholesterol levels and cardiovascular risk factors.

Authors:  W H Karge; J P Deluca; L J Marchitelli; C Champagne; R Tulley; J Rood; M A Paulos; H R Lieberman
Journal:  J Med Food       Date:  1999       Impact factor: 2.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.